Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

NCT02108002 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

NIH

Sponsor class

Conditions

Von Hippel-Lindau Disease

Interventions

DRUG: Vorinostat

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)